TL;DR
This study uses integrated metabolic modeling, culturing, and transcriptomics to show that Vibrio cholerae thrives in coinfections with E. coli due to metabolic cross-feeding, leading to enhanced virulence. This work identifies potential drug targets that are essential for V. cholerae in both single and coinfection scenarios, offering a broader spectrum of therapeutic strategies.
What Problem Does This Paper Address?
Most research on pathogen drug targets focuses on single-species infections. However, in reality, infections often involve multiple microbes (polymicrobial infections). This can significantly alter a pathogen's behavior, including its growth and essential gene requirements, making single-target strategies less effective. Specifically, Vibrio cholerae (causing cholera) and enterotoxigenic Escherichia coli (ETEC) frequently co-occur in diarrheal infections, and these dual infections are known to be more severe. The authors aim to understand how coinfection with ETEC impacts V. cholerae's metabolic capabilities and gene essentiality, and to identify drug targets that remain effective in these complex scenarios.
Methods
The researchers employed a multi-pronged approach:
- Genome-Scale Metabolic Modeling (GEMs): They constructed a detailed metabolic model of V. cholerae (iAM-Vc960) and a coinfection model combining V. cholerae and ETEC. These models simulate metabolic fluxes and predict growth under various conditions.
- In Vitro Culturing: They experimentally grew V. cholerae and ETEC together (cocultures) and separately (monocultures) to observe their growth dynamics.
- Dual RNA Sequencing (RNAseq): They analyzed the gene expression profiles of both pathogens during coculture to understand how their transcriptomes change in response to coinfection.
- In Silico Gene Essentiality Analysis: Using their models, they predicted which genes are essential for pathogen survival and growth, both in single infections and coinfections.
Datasets
- Genomic Data: The genome of V. cholerae V52 was sequenced and annotated. Existing genomic data for ETEC strains were also utilized.
- Metabolic Network Reconstructions: Previously published GEMs for ETEC and other enteric pathogens (like E. coli and Shigella) were used for comparison and to build the coinfection model.
- Experimental Gene Essentiality Data: Data from three independent studies on experimentally validated essential genes for V. cholerae were used to validate the model's predictions.
- Transcriptomic Data: Dual RNAseq data from cocultures and monocultures were generated and analyzed.
Key Insights and Ideas
- ETEC as a Metabolic Enabler: ETEC doesn't just coexist; it actively provides V. cholerae with essential metabolites (cross-feeding) that V. cholerae cannot produce itself. This is a major driver of V. cholerae's enhanced growth in coinfection.
- ETEC's Downside: While ETEC benefits V. cholerae, ETEC itself experiences suppressed growth in the coinfection. This suppression is likely due to non-metabolic factors, such as the type VI secretion system (T6SS) employed by V. cholerae.
- Transcriptomic Shifts: Coinfection significantly alters the gene expression landscape of V. cholerae, particularly in metabolic pathways, indicating a distinct physiological state compared to single infections.
- Druggable Targets in Polymicrobial Infections: The study highlights that essential genes can differ between single and coinfection scenarios. Identifying targets essential in both situations is crucial for developing broad-spectrum antimicrobials.
Key Results
- Enhanced V. cholerae Growth: Model predictions and in vitro experiments confirmed that V. cholerae grows significantly better when coinfected with ETEC compared to growing alone.
- ETEC Growth Suppression: Coculture experiments showed a decrease in ETEC abundance, likely mediated by V. cholerae's virulence factors.
- Metabolic Differences: V. cholerae was found to have less versatile metabolic capabilities than E. coli and Shigella, relying more on cross-feeding in coinfection.
- Gene Essentiality Discrepancies: In silico gene knockout simulations revealed that some genes essential for V. cholerae in single infections become non-essential in coinfection, and vice-versa.
- Identification of Core Essential Genes: The study identified 47 metabolic genes critical for V. cholerae growth in both single and coinfection settings, many of which are involved in cofactor biosynthesis and metabolism.
Limitations and Future Work
- Non-Metabolic Factors: The metabolic models could not fully explain the observed decrease in ETEC growth, suggesting that non-metabolic interactions (like T6SS activity) play a significant role and require further investigation.
- Model Refinement: The authors acknowledge that their V. cholerae model is not exhaustive and can be further refined with more experimental data.
- In Vitro vs. In Vivo: While the study integrates modeling and in vitro experiments, it notes that the human gut environment is more complex (hypoxic, varying pH, diverse commensals) and these factors are not fully captured.
- Future Directions: The authors suggest expanding models to include virulence factors, exploring the impact of environmental conditions (pH, oxygen), and validating the identified drug targets experimentally. They also propose applying this integrative framework to other polymicrobial infections.
Summary updated